Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems

Journal of Clinical Microbiology

Volumn 45, Issue 3, 2007, Pages 897-901

  Payan, Christopher ^a,d   Ducancelle, Alexandra ^c   Aboubaker, Mohamed H ^a   Caer, Julien ^c   Tapia, Malena ^a   Chauvin, Amelie ^c   Peyronnet, Damien ^c   Le Hen, Elodie ^c   Arab, Zohra ^a   Legrand, Marie Christine ^a   Tran, Adissa ^a   Postec, Edith ^b   Tourmen, Françoise ^c   Avenel, Martine ^a   Malbois, Chantal ^c   De Brux, Marie Anne ^c   Descamps, Philippe ^c   Lunel, Françoise ^c  

^a UNIVERSITÉ DE BREST   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; ASSAY; CANCER SCREENING; DNA SCREENING; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; KAPPA STATISTICS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; UNIVERSITY HOSPITAL; URINALYSIS; UTERINE CERVIX; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS LOAD; VIRUS TITRATION; WART VIRUS;

CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINE; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 33947209193     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02022-06     Document Type: Article

References (24)

1. Boom, R. C., J. Sol, M. M. Salimans, C. L. Jansen. P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
2. Brinkman, J. A., W. E. Jones, A. M. Gaffga, J. A. Sanders, A. K. Chaturvedi, J. Slavinsky III, J. L. Clayton, J. Dumestre, and M. E. Hagensee. 2002. Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J. Clin. Microbiol. 40:3155-3161.
3. Brinkman, J. A., M. Z. Rahmani, W. E. Jones, A. K. Chaturvedi, and M. E. Hagensee. 2004. Optimization of PCR based detection of human papillomavirus DNA from urine specimens. J. Clin. Virol. 29:230-240.
4. Castle, M., P. E. Schiffman, R. D. Burk, S. Wacholder, A. Hildesheim, R. Herrero, M. C. Bratti, M. E. Sherman, and A. Lorincz. 2002. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol. Biomarkers Prev. 11:1394-1399.
5. Dalstein, V. D., E. Riethmuller, J.-L. Pretet, K. Le Bail Carval, J.-L. Sautiere, J.-P. Carbillet, B. Kantelip, J.-P. Schaal, and C. Mougin. 2003. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int. J. Cancer 106:396-403.
6. Daponte, A. S., S. Pournaras, I. Mademtzis, C. Hadjichristodoulou, E. Kostopoulou, A. N. Maniatis, and I. E. Messinis. 2006. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J. Clin. Virol. 36:189-193.
7. Gaydos, M., C. A. Theodore, N. Dalesio, B. J. Wood, and T. C. Quinn. 2004. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J. Clin. Microbiol. 42:3041-3045.
8. Janssens, N., M. Janicot, T. Perera, and A. Bakker. 2004. Housekeeping genes as internal standards in cancer research. Mol. Diagn. 8:107-113.
9. Kleter, B. L., J. van Doorn, J. ter Schegget, L. Schrauben, K. van Krimpen, M. Burger, B. ter Harmsel, and W. Quint. 1998. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153:1731-1739.
10. Kleter, B. L., J. van Doorn, L. Schrauwen, A. Molijn, S. astrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
11. Lefevre, J., C. Hankins, K. Pourreaux, H. Voyer, F. Coutlee, and Canadian Women's HIV Study Group. 2004. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J. Med. Virol. 72:132-137.
12. Lorincz, P. E., A. T. Castle, M. E. Sherman, D. R. Scott, A. G. Glass, S. Wacholder, B. B. Rush, P. E. Gravitt, J. E. Schussler, and M. Schiffman. 2002. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228-229.
13. Monsonego, J. F., X. Bosch, P. Coursaget, J. T. Cox, E. Franco, I. Frazer, R. Sankaranarayanan, J. Schiller, A. Singer, T. C. Wright, Jr., W. Kinney, C. J. Meyer, J. Linder, E. McGoogan, and C. Meijer. 2004. Cervical cancer control, priorities and new directions. Int. J. Cancer 108:329-333.
14. Munoz, N. F., X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K, V. Shah, P. J. Snijders, C. J. Metjer, and International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
15. Perrons, C., R. Jelley, B. Kleter, W. Quint, and N. Brink. 2005. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J. Clin. Virol. 32:278-285.
16. Poljak, M. I., J. Marin, K. Seme, and A. Vince. 2002. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J. Clin. Virol. 25:589-97.
17. Pretet, J.-L., V. D. Dalstein, S. Monnier-Benoit, S. Delpeut, and C. Mougin. 2004. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women. J. Clin. Virol. 31:140-147.
18. Quint, W. G., S. R. Pagliusi, N. Lelie, E. M. de Villiers, C. M. Wheeler, and World Health Organization Human Papillomavirus DNA International Collaborative Study Group. 2006. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J. Clin. Microbiol. 44:571-579.
19. Sandri, M. T., P. Lentati, E. Benini, P. Dell'Orto, L. Zorzino, F. M. Carozzi, P. Maisonneuve, R. Passerini, M. Salvatici, C. Casadio, S. Boveri, and M. Sideri. 2006. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J. Clin. Microbiol. 44:2141-2146.
20. Sellors, A. T., J. W. Lorincz, J. B. Mahony, I. Mielzynska, A. Lytwyn, P. Roth, M. Howard, S. Chong, D. Daya, W. Chapman, and M. Chernesky. 2000. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 163:513-518.
21. Snijders, A. J., P. J. van den Brule, and C. J. Meijer. 2003. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J. Pathol. 201:1-6.
22. Toye, B., W. Woods, M. Bobrowska, and K. Ramotar. 1998. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J. Clin. Microbiol. 36:2356-2358.
23. van Ham, M. A., J. M. Bakkers, G. K. Harbers, W. G. Quint, L. F. Massuger, and W. J. Melchers. 2005. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J. Clin. Microbiol. 43:2662-2667.
24. van Hamont, D., M. A. van Ham, J. M. Bakkers, L. F. Massuger, and W. J. Melchers. 2006. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J. Clin. Microbiol. 44:3122-3129.